Does it matter where you go with an acute myocardial infarction?

1999; 33: 2092–197. [3] Kaski JC. The role of vascular endothelium in the modulation of coronary vasomotor tone. In: Salmasi A-M, Strano A eds. Angiology in Practice. Dordrecht: Kluwer, 1996: 53–62. [4] Ross R. Atherosclerosis — An Inflammatory Disease. N Engl J Med 1999; 3402: 115–26. [5] Awtry E, Loscalzo J. Aspirin. Circulation 2000; 101: 1206–18. [6] CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–39. [7] Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998; 97: 946–52. [8] Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial. Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA 1997; 277: 715–21. [9] Abrahamsson P, Dellborg M, Rosengren A, Wilhelmsen L. Improved long-term prognosis after myocardial infarction 1984–91. Eur Heart J 1998; 19: 1512–7. [10] The Heart Outcomes Prevention Evaluation Investigation. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53. [11] Picano E on behalf of the PISA (Persantin In Stable Angina) Study Group. Dipyridamole in chronic stable angina pectoris. A randomized, double blind, placebo-controlled, parallel group study. Eur Heart J 2001; 22: 1785–1793. [12] Wang T, Mentzer R, Van Wylen D. Interstitial adenosine with dipyridamole: effect on adenosine receptor blockade and adenosine deaminase. Am J Physiol 1992; 253: H552–8. [13] Tsuya T, Okada M, Horie H, Ishikawa K. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. Am J Cardiol 1990; 66: 275–8. [14] Sacks HS, Ancona-Berk VA, Berrier J, Nagalingam R, Chalmers TC. Dipyridamole in the treatment of angina pectoris: a meta-analysis. Clin Pharmacol Ther 1988; 43: 610–5. [15] Meininger CJ, Granger HJ. Mechanisms leading to adenosinestimulated proliferation of microvascular endothelial cells. Am J Physiol 1990; 258: H198–H206. [16] Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R, Kira Y. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 1994; 204: 318–24. [17] Torry RJ, O’Brien DM, Connell PM, Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol 1992; 262: H980–6.